Literature DB >> 8718464

Invasive fungal infections in children: recent advances in diagnosis and treatment.

T J Walsh1, C Gonzalez, C A Lyman, S J Chanock, P A Pizzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8718464

Source DB:  PubMed          Journal:  Adv Pediatr Infect Dis        ISSN： 0884-9404


× No keyword cloud information.
  16 in total

1.  Pharmacokinetics of itraconazole oral solution in neutropenic children during long-term prophylaxis.

Authors:  C Schmitt; Y Perel; J L Harousseau; S Lemerle; E Chwetzoff; J P le Moing; J C Levron
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.

Authors:  T J Walsh; P Whitcomb; S Piscitelli; W D Figg; S Hill; S J Chanock; P Jarosinski; R Gupta; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents.

Authors:  Thomas J Walsh; Peter C Adamson; Nita L Seibel; Patricia M Flynn; Michael N Neely; Cindy Schwartz; Aziza Shad; Sheldon L Kaplan; Maureen M Roden; Julie A Stone; Alisha Miller; Susan K Bradshaw; Susan X Li; Carole A Sable; Nicholas A Kartsonis
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Safety and tolerability of fluconazole in children.

Authors:  V Novelli; H Holzel
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

5.  Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis.

Authors:  R Santangelo; P Paderu; G Delmas; Z W Chen; R Mannino; L Zarif; D S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 6.  Treatment of invasive Aspergillosis in children with hematologic malignancies.

Authors:  Walid Abuhammour; Rashed A Hasan
Journal:  Indian J Pediatr       Date:  2004-09       Impact factor: 1.967

Review 7.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

8.  Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes.

Authors:  J Kevin Hicks; Kristine R Crews; Patricia Flynn; Cyrine E Haidar; Calvin C Daniels; Wenjian Yang; John C Panetta; Deqing Pei; Jeffrey R Scott; Alejandro R Molinelli; Ulrich Broeckel; Deepa Bhojwani; William E Evans; Mary V Relling
Journal:  Pharmacogenomics       Date:  2014-06       Impact factor: 2.533

Review 9.  Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.

Authors:  Helen W Boucher; Andreas H Groll; Christine C Chiou; Thomas J Walsh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Invasive aspergillosis in children with hematologic malignancies.

Authors:  Rashed A Hasan; Walid Abuhammour
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.